- What changed in FBIO news today?
- Fortress Biotech Q3 revenue rises 9% as dermatology sales drive growth: Fortress Biotech’s third-quarter net revenue rose 9% year over year to $19.2 million, mainly on higher marketed dermatology sales, while it reported an $8.25 million net loss. Cash was $152.2 million at September 30, and repayment of its $15 million credit facility left no parent-level debt.
- Does Rallies summarize FBIO news?
- Yes. Rallies summarizes FBIO news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
- Is FBIO research on Rallies investment advice?
- No. Rallies provides research, data, and educational context for FBIO. It does not provide personalized investment advice.